close

Enter

Log in using OpenID

Tissue Diagnostic Market Growth Prospects With Challenges

embed
Tissue diagnosis is important tool in diagnosis, monitoring, and management of different types of cancer conditions.
Tissue Diagnostic Market Size, Share, Trend,
Outlook, Future Growth Analysis And
Synthesis 2018 - 2026
Tissue diagnosis is important tool in
conditions. Recognition of sign and
sample from region of interest such
done to look for cancer detection or
diagnosis, monitoring, and management of different types of cancer
symptoms of disease are done through biopsy, a process of taking
as skin, tissue or tumor for further diagnosis. Biopsy are primarily
to detect rejection of transplanted organ draft.
Biopsy is done to identify likely cause of cancerous and non-cancerous tissue, which are unable to detect
through CT-scan or X-rays. Depending on area of sample collection various biopsy procedures are done
such as endoscopic biopsy, bone marrow biopsy, skin biopsy, kidney biopsy, liver biopsy, and prostate
biopsy. Furthermore biopsy can be done using needle biopsy, CT guided biopsy, Ultrasound biopsy, and
surgical biopsy for the tissue diagnostic. According to the American journal of Nephrology, 2015,
Australia has the highest numbers of annual renal biopsy rates (215 persons/million person/year)
followed by the Finland (176 persons/million person/year) and U.S. (175 persons/million person/year).
The increased numbers of biopsy procedure likely to fuel the growth of tissue diagnostic market, in near
future.
Get Exclusive Sample Copy of Tissue Diagnostic Research @
https://www.coherentmarketinsights.com/insight/request-sample/1112
Rising prevalence of different cancer incidences is major driving factor boosting the tissue diagnostic
market. According to American cancer Society (ACS), 1.6 million new cases of cancer diagnosed in the
U.S., in 2016. In addition, increase research funding in cancer treatment and growing healthcare
expenditure likely to show gradual rise in tissue diagnostic market. National Cancer Institute, in 2015,
spends US$ 4,480 million on various types of cancer research which includes breast cancer, colorectal
cancer, cervical cancer, liver cancer, lung cancer, leukemia, ovarian cancer and uterine cancer.
Rise in the prevalence of cancer incidences to boost the tissue diagnostic market
According to the United States Cancer statistics report published in 2014 by Centers of Disease Control
and Prevention (CDC), between 1999 and 2014, more than 1600 people a day, died due to the cause of
cancer. Although screening tests helps to detect cancer condition at early stage, data from Healthy
People 2020, an initiative form Department of Health and Human Services, reveals that screening rate is
still below the national targets set. Combined data collected from CDC and National cancer institute
(NCI) focus on the top 3 cancer incidences in male and female. In male prostate cancer incidence are
higher, while in females breast cancer are most dominated, followed by lung and colon cancer
respectively in both male and female.
New and advanced methods of tissue diagnosis favors the market growth
Innovation in tissue diagnostic process for the efficient diagnostic testing such as Fluorescence in situ
hybridization (FISH), Immunohistochemistry (IHC) and In situ hybridization (ISH) raises the opportunity
to grow tissue diagnostic market in future. In September 2017, researchers at the University of Texas,
developed a new way of diagnosis by creating pen named as “MasSpec Pen”, which is handheld devices
able to distinguish healthy tissue and tumor tissue in just 10 seconds, more than 150 times quicker than
existing technology. These new tool provides improvement in cancer treatment and minimizes the
chances of recurrence by offering precise diagnostic information, which eventually favors the growth in
tissue diagnostic market.
Report includes chapters which deeply display the following deliverable about industry :
• Tissue Diagnostic Market Research Objective and Assumption
• Tissue Diagnostic Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Tissue Diagnostic Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Tissue Diagnostic Market, By Regions
• Tissue Diagnostic Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Tissue Diagnostic Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Tissue Diagnostic Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Tissue Diagnostic Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Global Eminent Players
Key players operated in the tissue diagnostic market are Biocare Medical, Agilent technologies, Thermo
Fisher Scientific, Sigma-Aldrich, Roche Diagnostics, Danaher corp., Biogenex Laboratories, Life
Technologies and Abbott laboratories.
Tissue diagnostic market taxonomy:
By Technology:
•
In situ hybridization
•
Digital pathology
•
Immunohistochemistry
•
Tissue microarray
•
Special staining
By Disease:
•
Breast cancer
•
Lymphoma cancer
•
Gastric cancer
•
Prostate cancer
Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoinginsight/tissue-diagnostic-market-1112
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Poul Master
Poul Master240   documents Email
Document
Category
Health and Medicine
Views
3
File Size
121 KB
Tags
Tissue Diagnostic Market, diagnostics
1/--pages
Report inappropriate content